Stock listing

DBV Stock Price, News, Filings & Events — Dbv Technologies Sa

Selected listing: DBV · XETR · EUR · DE

This page tracks Dbv Technologies Sa's DBV:XETR listing on XETR in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DBV:XETR. DBV:XETR is the stock-level entry point for investors researching Dbv Technologies Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dbv Technologies Sa is a public company listed on the French market under the ticker DBV, with a market capitalization of approximately €799.37 million. The company focuses on developing innovative treatments for food allergies and other immunological diseases. Its commitment to advancing healthcare solutions positions it as a key player in the biotechnology sector.

DBV:XETREURDEUpdated August 28, 2026
Dbv Technologies Sa logo
Ticker
DBV:XETR
Asset type
Stock
Market cap
$907.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
XETR
Currency
EUR

Dbv Technologies Sa DBV:XETR stock context

This page tracks Dbv Technologies Sa's DBV:XETR listing on XETR in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DBV:XETR. DBV:XETR is the stock-level entry point for investors researching Dbv Technologies Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dbv Technologies Sa is a public company listed on the French market under the ticker DBV, with a market capitalization of approximately €799.37 million. The company focuses on developing innovative treatments for food allergies and other immunological diseases. Its commitment to advancing healthcare solutions positions it as a key player in the biotechnology sector.

Latest news from Dbv Technologies Sa

All Dbv Technologies Sa news →

Dbv Technologies Sa earnings calls

Research Dbv Technologies Sa

Alternate listings